Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Share Option Schemes

17 Dec 2008 07:00

RNS Number : 2663K
Imaginatik PLC
17 December 2008
 



17 December 2008

Imaginatik Plc

("Imaginatik" or the "Company")

Share Option Schemes

Imaginatik plc (AIM: IMTK), a leading provider of cost reduction, process improvement and collaborative innovation software and processes, announces that on 12 December 2008, the remuneration committee of the Board approved the re-basing of the exercise price of all share options in issue at that date, to 4p per share, in order to give the management team and employees an effective incentive in this recognisably harder financial environment.

The Company has two share option schemes in place. The Imaginatik Plc Enterprise Management Incentive Scheme (the "Share Option Scheme") and the Imaginatik 2006 Stock Option Plan (the "Stock Option Plan"). There are 6,746,666 share options over ordinary shares of 0.0625p each outstanding under the Share Option Scheme and 3,787,500 share options over ordinary shares of 0.0625p each outstanding under the Stock Option Plan. In addition, there are 2,632,679 share options outstanding under the unapproved share option scheme. Mr. Mark Turrell, CEO and majority shareholder does not hold any options in the Company. 

No other changes to the share option deeds, dated 11 December 2006, have been made.

Mark Turrell, Chief Executive Officer commented, "We have been pleased with the performance of the Company over the last 12 months and it is the view of the Board that the rebasing of the share options to this level represents the best means by which we can ensure that our employees continue to be well incentivised. Incentivisation is something which we regard as crucial, especially in the current climate and we believe that the shareholders will enjoy benefits earlier if our personnel have a more achievable interest in the success of Imaginatik."

For further information please contact: 

Imaginatik plc Tel: 020 7917 2975 

Mark Turrell, CEO / Shawn Taylor, CFO 

W.H. Ireland Limited Tel: 0121 265 6330 

Tim Cofman / Katy Birkin 

ICIS Tel: 020 7651 8688 

Caroline Evans-Jones / Mike Smith 

About Imaginatik 

Imaginatik is the leading provider of cost reduction, process improvement and collaborative innovation software and processes to the world's leading companies. More than 100 clients rely on Imaginatik's software, consulting and research to enable their best-of-breed innovation activities. 

Named as a World Economic Forum Technology Pioneer for 2008 and a finalist for the IBM Lotus Awards 2008 in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings, process improvements and increased product pipeline. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as the London Business School and the Cass School of Business, London, as well as leading practitioners of corporate innovation. 

For further information please visit www.imaginatik.com 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSILFLTFFLRLIT
Date   Source Headline
25th Jan 201211:30 amRNSHolding(s) in Company
23rd Jan 20127:01 amRNSContract Renewals worth £1.1m
3rd Jan 20127:00 amRNSDirectorate Change
22nd Dec 20117:00 amRNSContract extension
14th Dec 20117:00 amRNSLitigation Update
12th Dec 20117:00 amRNSContract Win
28th Nov 20117:00 amRNSHalf Yearly Report
28th Oct 20112:13 pmRNSChange of Adviser
28th Oct 201110:02 amRNSHolding(s) in Company
27th Oct 201110:45 amRNSHolding(s) in Company
13th Oct 20117:00 amRNSContract Extension
3rd Oct 201112:28 pmRNSDirectorate Change
26th Sep 20115:12 pmRNSResult of AGM
15th Sep 201110:24 amRNSHolding(s) in Company
2nd Sep 20113:25 pmRNSNotice of AGM
31st Aug 201111:46 amRNSHolding(s) in Company
26th Aug 20113:30 pmRNSResult of Open Offer and General Meeting
4th Aug 20119:32 amRNSPosting of Circular
2nd Aug 20117:15 amRNSProposed Placing, Subscription and Open Offer
2nd Aug 20117:00 amRNSFinal Results
29th Jul 201112:10 pmRNSNotice of Results
26th Apr 20117:00 amRNSIssue of Equity
14th Apr 20117:00 amRNSContract with the World Bank
1st Mar 20117:00 amRNSContract Wins and Trading Update
25th Jan 201111:22 amRNSWithdrawal of requisition of General Meeting
12th Jan 201111:01 amRNSHolding(s) in Company
11th Jan 20115:26 pmRNSIssue of Equity
22nd Dec 201012:24 pmRNSResult of General Meeting
22nd Dec 20107:00 amRNSFurther Requisition of General Meeting
16th Dec 20107:00 amRNSHalf Yearly Report
1st Dec 201010:08 amRNSNotice of General Meeting
19th Nov 20107:00 amRNSBoard Appointment
15th Nov 20103:28 pmRNSRequisition of General Meeting
11th Oct 20107:00 amRNSContract Extension with Pfizer
4th Oct 201011:58 amRNSShare Option Schemes
29th Sep 201011:41 amRNSResult of AGM
29th Sep 20107:00 amRNSAGM Statement
10th Sep 20105:00 pmRNSHolding in Company
10th Sep 20103:36 pmRNSHolding(s) in Company
10th Sep 20107:00 amRNSPilot Project Established with NASA
9th Sep 201012:47 pmRNSHolding(s) in Company
6th Sep 20104:14 pmRNSIssue of Equity
24th Aug 20103:16 pmRNSResult of General Meeting
18th Aug 20101:23 pmRNSMarket Update
6th Aug 20106:28 pmRNSPosting of Circular
30th Jul 20104:41 pmRNSHolding(s) in Company
27th Jul 20104:33 pmRNSPosting of Circular convening General Meeting
22nd Jul 201011:53 amRNSHolding(s) in Company
7th Jul 201011:04 amRNSSenior Management Team Appointments
23rd Jun 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.